Previous Article | Next Article 
Infection and Immunity, February 2000, p. 752-759, Vol. 68, No. 2
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Activation of Human Peripheral Blood Mononuclear
Cells by Nonpathogenic Bacteria In Vitro: Evidence of NK Cells as
Primary Targets
D.
Haller,1,2,*
S.
Blum,3
C.
Bode,1
W. P.
Hammes,2 and
E.
J.
Schiffrin3
Institute of Biological Chemistry and
Nutrition Science1 and Institute of Food
Technology,2 University Hohenheim, D-70599
Stuttgart, Germany, and Department of Immunology, Nestlé
Research Centre, 1000 Lausanne 26, Switzerland3
Received 23 August 1999/Returned for modification 7 October
1999/Accepted 4 November 1999
 |
ABSTRACT |
The interaction of commensal bacteria with immunocompetent cells
may occur in definite compartments of the mucosal immune system, as
limited translocation through the epithelial barrier cannot be
excluded. In this study the stimulation of human peripheral blood
mononuclear cells and purified lymphocyte subsets by nonpathogenic gram-positive lactobacilli (Lactobacillus johnsonii and
Lactobacillus sakei) and gram-negative Escherichia
coli was investigated. The various bacterial strains induced a
differential cytokine pattern. Whereas L. johnsonii and
L. sakei strongly induced gamma interferon (IFN-
) and
interleukin-12 (IL-12), E. coli and lipopolysaccharide (LPS) preferentially induced IL-10 after 16 h of stimulation. Expression of activation antigens CD69 and CD25 was observed on (CD3
CD56+) natural killer (NK) cells after
stimulation of total human peripheral blood mononuclear cells. All
bacteria mediated the proliferation of human peripheral blood
mononuclear cells, and the strongest proliferative response was
observed with L. johnsonii. Purified CD4+,
CD8+, and CD19+ lymphocyte subsets were not
activated upon bacterial stimulation but showed normal response to a
mitogenic stimulus. In contrast, purified NK cells upregulated the
IL-2R
chain (CD25) and underwent proliferation when stimulated by
L. johnsonii. E. coli and LPS were less effective in
inducing proliferation. Expression of CD25 or secretion of IFN-
from
purified NK cells was significantly increased in the presence of
bacterially primed macrophages, indicating that full activation
required both bacterium- and cell contact-based signals derived from
accessory cells.
 |
INTRODUCTION |
The microflora is essential for
immune education and amplification of lymphoid effector cells, mainly
at the mucosal level. It is well documented that the efficacy of the
mucosal immune system can be significantly impaired in germ-free
animals (3, 20). Lactobacilli are members of the normal
indigenous microflora (8, 23), and certain strains of
Lactobacillus spp. have been used as probiotics
(16). Recently, the modulation of human innate immune
defenses following ingestion of specific lactic acid bacteria (LAB) was
reported (25, 35, 37). Although the interaction between
commensal, nonpathogenic bacteria and blood leukocytes seems to be an
unusual event, it might occur in definite microenvironments of the
mucosal immune system. The M-cell pockets harbor different types of
immunocompetent cells, and a limited bacterial translocation through
the epithelial barrier cannot be excluded (6, 32). The
capacity to translocate enables bacteria to interact with cells of the
immune system.
The investigation of interactions of nonpathogenic bacteria with
leukocytes in vitro is of particular interest (i) to evaluate the
immunomodulatory capacity of intestinal or food-fermenting bacteria on
blood leukocytes and (ii) to investigate if a distinct pattern of
immunomodulation can be established for different components of the
microflora. In vitro, several species of lactobacilli have been shown
to induce cytokines, such as tumor necrosis factor alpha (TNF-
) and
interleukin-12 (IL-12) in human peripheral blood mononuclear cells
(PBMC) (18, 28). IL-12, like gamma interferon (IFN-
), is
an important cytokine implicated in innate defense mechanisms in
response to bacteria. Early production of IL-12 by macrophages
contributes to effector cell maturation for both natural killer (NK)
cells and CD8+ T cells, leading to a Th1-biased adaptive
immune response (4, 5, 17, 26). The majority of circulating
NK cells are CD3
CD56+ CD16+ (80 to 90%); a minority are CD3
CD56+
CD16
(19, 22). Morphologically they are very
large granular lymphocytes and have the ability to migrate into
tissues. The vast majority of NK cells are found in the liver, but they
can also invade mucosal sites (34). NK cells provide a first
line of defense against tumors, viral infections, and intestinal
pathogens and thus have a key role in innate immunity (4, 21,
26).
This study provides data on the immunostimulatory effect of the
nonpathogenic Escherichia coli and Lactobacillus
(LAB) strains of human intestinal or fermented food origin, such as
Lactobacillus johnsonii La 1 and Lactobacillus
sakei LTH 681, on human peripheral blood mononuclear cells (PBMC)
and purified leukocyte supopulations (CD4+,
CD8+, CD19+, and CD56+ cells). We
present results for a different cytokine patterns induced by
gram-negative and gram-positive bacteria and show evidence that NK
cells constitute primary targets for bacterially mediated activation.
 |
MATERIALS AND METHODS |
Bacteria.
The gram-negative, nonpathogenic E. coli K-12 LTH 634 (strain collection of the Institute of Food
Technology, University of Hohenheim) was grown in brain heart infusion
broth at 37°C. The gram-positive L. johnsonii La 1 (Nestlé strain collection) of human intestinal origin was
cultivated in MRS broth (7) without acetate at 37°C.
L. sakei LTH 681, isolated from fermented food, was grown in
the same broth at 30°C. All bacteria were harvested by centrifugation
(3,000 × g, 15 min) at stationary growth phase (24 h).
Bacteria were washed three times with phosphate-buffered saline (PBS)
(1×, pH 7.2; Gibco BRL) and subsequently diluted to final
concentrations of 105 and 106 CFU/ml in RPMI
1640 (Gibco BRL) medium containing 20% native human AB serum (Sigma).
Bacteria were either heat killed (100°C, 30 min) or used as live cells.
Isolation of human PBMC.
Human PBMC were purified from buffy
coats (Blood Transfusion Centre, Lausanne, Switzerland) using
Ficoll-Hypaque (1077; Pharmacia) gradient centrifugation. PBMC were
harvested from the interface, washed five times with RPMI 1640, and
diluted in RPMI 1640 containing 20% native human AB serum to a final
concentration of 2 × 106/ml.
Purification of lymphocyte subpopulations.
PBMC were
incubated in RPMI 1640-20% fetal calf serum (FCS) for 1.5 h at
37°C and 5% CO2 on 225-cm2 tissue culture
plates (Costar) to allow adherence. Nonadherent peripheral blood
lymphocytes (PBL) were separated from adherent cells by aspiration.
Adherent cells were gently washed three times with prewarmed culture
medium, harvested by using a rubber policeman (Costar), and used as
monocytes/macrophages. Thereafter, PBL were washed with RPMI 1640. CD4+, CD8+, and CD19+ lymphocyte
subsets were purified from PBL by magnetic cell sorting (MACS) using a
positive selection technique. Briefly, the PBL suspension was labeled
with CD4+, CD8+, and CD19+ MACS
microbeads (Miltenyi Biotec) for 10 min at 4°C, washed once with 1×
PBS-5% FCS, and dissolved in 1 ml of PBS-5% FCS. Labeled cells were
then transferred to a high-gradient magnetic separation column placed
in a magnetic field. After four washings with PBS-5% FCS, positive
labeled cells remained on the column while nonlabeled cells passed
through. After removal of the columns from the magnetic field, the
labeled cells were recovered by elution. NK cells were isolated by an
indirect magnetic labeling system according to the supplier's protocol
(Miltenyi Biotec). The purity was controlled by flow cytometry analysis
(FACScan; Becton Dickinson) analysis using fluorescein isothiocyanate
(FITC)-phycoerythrin (PE)-labeled anti-CD4/CD8 (Becton Dickinson)
monoclonal antibody (MAb), FITC-labeled anti-CD19 MAb (Becton
Dickinson), FITC-labeled anti-CD56 MAb (Becton Dickinson), and
PE-labeled anti-CD3 MAb (Becton Dickinson). The purities of isolated
lymphocyte subpopulations ranged between 94 and 98%. Finally, purified
lymphocyte subsets were diluted in cell culture medium as described
above to a final density of 2 × 106/ml.
Stimulation of PBMC or lymphocyte subsets.
Freshly isolated
PBMC or purified lymphocyte subsets were seeded at 2 × 106/ml (2 ml) into six-well tissue culture plates, and 2 ml
of bacterial suspension was added to each well. For the stimulation,
the final ratio between PBMC and bacteria (live or heat-killed) was 1:1 or 10:1. For control treatment, lipopolysaccharide (LPS; E. coli serotype O55:B5; 1 µg/ml; Sigma) or culture medium alone
was added to the PBMC suspension. To determine the cytokine expression
by PBMC, the samples were incubated in the absence of antibiotics for
2, 6, and 16 h at 37°C and 5% CO2. Subsequently,
PBMC were collected, washed in cold PBS, and centrifuged and the cell
pellet was lysed in guanidinium isothiocyanate denaturation solution. Cellular lysates were kept at
20°C until further processing. Cell
culture supernatants were collected separately and kept at
20°C for
cytokine analysis using the enzyme-linked immunosorbent assay (ELISA)
technique. For flow cytometric analysis, PBMC were challenged by
bacterial suspensions, LPS (E. coli serotype O55:B5; 1 µg/ml; Sigma), or phytohemagglutinin (PHA; 10 µg/ml; Sigma) for 3 and 5 days in the presence of gentamicin (125 µg/ml; Gibco BRL).
Expression of activation antigens on PBMC or lymphocyte
subsets.
PBMC, purified CD4+, CD8+, and
CD19+ lymphocytes, and CD3
CD56+
NK cells (106 cells/ml) were stimulated for 3 or 5 days
with live bacteria (106 cells/ml), PHA (10 µg/ml), or LPS
(1 µg/ml) as described above. To prevent bacterial overgrowth,
gentamicin (125 µg/ml) was added to the culture medium. Thereafter,
cells were washed (Cell Wash; Becton Dickinson) and double stained with
directly conjugated MAb CD69-FITC or CD25-FITC and CD4
CD8
CD19
CD56
PE (Becton
Dickinson) for 30 min on ice, washed two times, centrifuged, and
resuspended in Cell Wash (Becton Dickinson). The percentage of CD69- or
CD25-positive cells within the lymphocyte subpopulations was compared
to that for nontreated cells using flow cytometry (FACScan; Becton Dickinson).
Priming of monocytes with nonpathogenic bacteria.
Monocytes/macrophages were incubated with 106 CFU of live
E. coli, L. johnsonii, or L. sakei/ml
for 12 h, harvested by scraping, and washed three times with PBS
buffer. Cell viability was controlled by trypan blue exclusion and was
generally >90%.
Cocultivation of purified NK cells with primed macrophages.
Purified CD56+ CD3
NK cells
(106/ml) were incubated in the presence of gentamicin (125 µg/ml) with (i) bacterially primed monocytes (5 × 105 cells/ml), (ii) a mixture of nonprimed monocytes
(5 × 105 cells/ml) and live bacteria (106
CFU/ml), or (iii) bacteria alone (106 CFU/ml). Incubation
of NK cells and untreated monocytes (5 × 105
cells/ml) served as a control. To characterize to what extent cell-to-cell interaction is involved in the activation of NK cells by
nonpathogenic bacteria, NK cells were coincubated with bacterially primed monocytes separated by cell culture inserts (pore size, 0.4 mm).
After 3 and 5 days of stimulation, the percentage of CD69- or
CD25-positive NK cells in the basolateral compartment was compared to
that for noncocultured NK cells using flow cytometry. Supernatants were
frozen for ELISA analysis.
RNA extraction and amplification by RT-PCR.
Total RNA from
PBMC or leukocyte subpopulations was isolated using the acid
guanidinium thiocyanate-phenol-chloroform method (Micro RNA isolation
kit; Stratagene). cDNA was synthesized from RNA by reverse
transcription (RT) of 0.5 µg of total RNA at 42°C for 30 min using
specific 3' priming, a 1 mM concentration of each deoxynucleoside
triphosphate, and 2.5 U of murine leukemia virus reverse transcriptase
(Perkin-Elmer)/ml. PCR amplification was performed using Taq
polymerase (Perkin-Elmer) and specific primers coding for the human
cytokines TNF-
, IL-12, IL-10, IFN-
, and
-actin in a total
volume of 50 µl. Thermocycles were run at 94°C (1 min), 94°C (1 min), 60°C (1 min), and 72°C (1 min) for 30 cycles. PCR products
were analyzed on 2% agarose gels. The oligonucleotide primers used
were as follows: TNF-
(5'), 5'-CAGAGGGAAGAGTTCCCCAG-3'
and (3') 5'-CCTTGGTCTGGTAGGAGACG-3' (product length,
324 bp); IL-12 p40 (5'), 5'-CGTAGAATTGGATTGGTATCCGG-3' and
(3') 5'-GCTCTTGCCCTGGACCTGAACGC-3' (product length, 702 bp); IFN-
(5'), 5'-ATATCTTGGCTTTTCAGCTC-3' and (3')
5'-CTCCTTTTTCGCTTCCCTGT-3' (product length, 489 bp); IL-10
(5'), 5'-TGATGTCTGGGTCTTGGTTC-3' and (3')
5'-GCCTAACATGCTTCGAGATC-3' (product length, 204 bp); and
-actin (5'), 5'-GGCGACGAGGCCCAGGAGCAAGAGAGGCATC-3' and
(3') 5'-CGATTTCCCGCTCGGCCGTGGTG-GTGAAGC-3' (product length,
460 bp).
Proliferation assay.
PBMC or purified lymphocyte subsets
were diluted in complete RPMI 1640 medium to a final concentration of
105/ml. The PBMC suspension was then transferred to 96-well
flat-bottom culture plates (Costar), and 100 µl of RPMI 1640 medium
containing 2 × 104 to 2 × 107 CFU
of bacteria/ml, LPS (2 µg/ml), or PHA (20 µg/ml) was added. Cells
were stimulated in the presence of gentamicin (125 µg/ml) for 3 and 5 days at 5% CO2 and 37°C. Finally, the cells were pulsed with 1 µCi of [3H]thymidine for 18 h before being
harvested on filter mats. Analysis of [3H]thymidine
incorporation was by liquid scintillation counting (TopCount; Packard).
ELISA.
Cytokine concentration in cell culture supernatants
(IFN-
, IL-10, IL-12 p70, and TNF-
) was determined after 16 h
of bacterial stimulation using ELISA (ImmunoKontact). Dose-response
experiments performed for each cytokine indicated that maximal
secretion was obtained with 106 CFU of bacteria/ml,
corresponding to a ratio of 1:1 (bacteria to PBMC). This concentration
was used in further experiments.
Statistics.
Values are given as the means of triplicate
measurements ± standard deviations (SD). Results were confirmed
for at least three different blood donors in independent experiments.
The significance was tested by applying the Mann-Whitney U test.
 |
RESULTS |
Gram-positive and gram-negative nonpathogenic bacteria
differentially induce cytokine expression in human PBMC.
Freshly
isolated PBMC were stimulated by nonpathogenic gram-positive L. johnsonii or L. sakei or gram-negative E. coli at a ratio of 1:1 (live or heat-killed bacteria to PBMC) for
2, 6, and 16 h in RPMI 1640-10% human AB serum. No bacterial
overgrowth of the antibiotic-free cultures was detected at the given
time point as controlled by the plating or nonacidification of the culture medium (phenol red indicator). RT-PCR analysis of total RNA
extracted from PBMC after stimulation showed an early induction (2 h)
of gene transcripts for IFN-
by both Lactobacillus
strains. The level of induction was increased within 6 h and
stayed high at 16 h. In contrast, the E. coli-mediated
IFN-
mRNA induction was very low at the early time points and was
completely abrogated at 16 h. LPS did not induce IFN-
mRNA at
any time point investigated (Fig. 1,
right). The amount of IFN-
secreted into cell culture supernatants
was determined after 16 h of bacterial stimulation using ELISA
techniques. The predominant induction of IFN-
in human PBMC by the
two LAB strains was also confirmed at the secretory level, where
significant amounts of IFN-
(1,500 pg/ml) were detectable in cell
culture supernatants compared to the amounts induced in E. coli- (200 pg/ml) or LPS-stimulated PBMC. Soluble LPS was unable to induce IFN-
, confirming the results obtained by RT-PCR analysis (Fig. 1, left).

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 1.
Expression of IFN- by PBMC upon stimulation with
nonpathogenic bacteria. RT-PCR and ELISA analyses were used to
determine IFN- expression by PBMC (106/ml) upon
stimulation with heat-killed (gray bars) and live (black bars)
bacterial cells (106 CFU/ml) of E. coli,
L. johnsonii, or L. sakei or LPS (1 µg/ml).
Gene transcription (IFN- , IL-12 p40) was determined after 2, 6, and
16 h. Protein secretion was analyzed after 16 h of
stimulation. No antibiotics were added to the cultures. Values are
means ± SD of triplicate measurements and represent one of three
independent experiments.
|
|
In contrast to IFN-
, IL-12 p40 mRNA was strongly induced by all
bacterial treatments after 6 and 16 h, with higher levels of
induction for lactobacilli. E. coli and LPS, although
weaker, induced significant IL-12 p40 mRNA levels compared to the
untreated control (Fig. 2, right). However, IFN-
secretion was
exclusively induced by LAB. Neither E. coli nor soluble LPS
(1 µg/ml) induced any secretion of IL-12 p70 above background levels
(Fig. 2, left). A distinct induction of IL-10 mRNA was observed only at
6 h with the E. coli treatment. At 16 h, IL-10
mRNA was induced by all bacteria except L. sakei. Notably,
IL-10 transcripts were also expressed in untreated PBMC. The analysis
of secreted IL-10 in cell culture supernatants provided more conclusive
results: only the gram-negative E. coli and gram-negative
bacterium-derived soluble factor LPS (P < 0.001) were
potent stimulators of IL-10 secretion, probably by direct activation of
macrophages (Fig. 3). Whereas for the
other cytokines no differences in the stimulatory activities of live
and heat-killed bacteria used at the same concentration could be
observed, IL-10 secretion by PBMC was significantly greater with live
than with heat-killed E. coli (P < 0.01).
No differences in the amounts of TNF-
production (7,000 pg/ml for
bacteria, 3,500 pg/ml control) following the stimulation of PBMC with
the different bacterial strains could be observed (data not shown).

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 2.
Expression of IL-12 by PBMC upon stimulation with
nonpathogenic bacteria. RT-PCR and ELISA analyses were used to
determine IL-12 expression by PBMC (106/ml) upon
stimulation with heat-killed (gray bars) and live (black bars)
bacterial cells (106 CFU/ml) of E. coli,
L. johnsonii, or L. sakei or LPS (1 µg/ml).
Gene transcription (IL-12 p40) was determined after 2, 6, and 16 h. Protein secretion (IL-12 p70) was analyzed after 16 h of
stimulation. No antibiotics were added to the cultures. Values are
means ± SD of triplicate measurements and represent one of three
independent experiments.
|
|
Expression of activation antigens CD69 and CD25 (IL-2R
chain) on
PBMC upon bacterial challenge.
CD69, a marker of leukocyte
activation, was determined on lymphocyte subsets (CD4+,
CD8+, and CD19+) and natural killer (NK) cells
(CD3
CD56+) at day 3 after stimulation of
bulk cultures (gentamicin at 125 µg/ml) using flow cytometry. All
bacterial strains (106 CFU/ml; live cells) and LPS (1 µg/ml) induced CD69 expression preferentially on NK cells (<30%
CD69+ cells) and to a lesser extent on CD8+
cells (12 to 15%). CD4+ and CD19+ cells
remained unresponsive to bacterial stimulation. The mitogenic stimulus
PHA (10 µg/ml) preferentially activated CD4+ and
CD8+ T cells, demonstrating the general responsiveness of T
lymphocytes (Fig. 4). The induction of
the IL-2R
chain (CD25) constitutes an important step in the
generation of high-affinity IL-2R, necessary to enter cell cycling,
followed by proliferation. As for the expression of CD69, we detected
the expression of CD25 after bacterial treatment only on NK cells at
day 5 poststimulation. The highest level of expression was observed
with L. johnsonii (P < 0.05 compared to that for E. coli). T and B cells remained unresponsive to
bacterial activation, although the response to PHA was normal (Fig.
5).

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 3.
Expression of IL-10 by PBMC upon stimulation with
nonpathogenic bacteria. RT-PCR and ELISA analyses were used to
determine IL-10 expression by PBMC (106/ml) upon
stimulation with heat-killed (gray bars) and live (black bars)
bacterial cells (106 CFU/ml) of E. coli,
L. johnsonii, or L. sakei or LPS (1 µg/ml).
Gene transcription was determined after 2, 6, and 16 h. Protein
secretion was analyzed after 16 h of stimulation. No antibiotics
were added to the cultures. Values are means ± SD of triplicate
measurements and represent one of three independent experiments.
|
|

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 4.
Expression of the cellular activation antigen CD69 on
lymphocyte subsets (CD4+, CD8+, and
CD19+) and NK cells (CD3 CD56+).
PBMC (106/ml) were stimulated with live E. coli,
L. johnsonii, and L. sakei cells (106
CFU/ml) and LPS (1 µg/ml). PHA (10 µg/ml) and culture medium were
used as controls. FACS analysis was performed to determine CD69
expression on lymphocyte subsets (CD4+, CD8+,
and CD19+) and NK cells (CD3
CD56+) after 3 days of stimulation. Gentamicin (125 µg/ml) was added to the cultures. Values are means of duplicate
measurements and represent one of three independent experiments.
|
|
Bacterially mediated induction of proliferation in human PBMC and
purified NK cells.
Proliferation of PBMC was determined after 3 and 5 days of stimulation with LAB strains, E. coli, LPS (1 µg/ml), or PHA (10 µg/ml) by measuring [3H]thymidine
incorporation. As shown in Fig. 6, all
bacteria (live cells) induced significant proliferation of PBMC after 5 days of culture. L. johnsonii was the strongest effector,
producing levels comparable with the levels obtained with the mitogenic stimulus. For the stimulation of lymphocyte subsets L. johnsonii and E. coli were chosen as representative
gram-positive and gram-negative strains, respectively. Stimulation of
purified CD4+, CD8+, and CD19+
lymphocytes did not result in proliferation with any of these strains
(data not shown). However, purified CD3
CD56+
NK cells proliferated upon bacterial stimulation for 5 days, although
the proliferative response was 10 times lower than that for total PBMC,
suggesting that (i) only a subpopulation of NK cells was stimulated by
bacteria or LPS or (ii) stimulation with bacteria alone was suboptimal.
L. johnsonii had a significantly greater stimulatory effect
than E. coli and LPS (P < 0.05) (Fig. 7). Experiments performed with
heat-killed bacteria in the absence of gentamicin exhibited results
similar to those for live bacteria (data not shown).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 5.
Expression of the cellular activation antigen CD25
(IL-2R chain) on lymphocyte subsets (CD4+,
CD8+, and CD19+) and NK cells
(CD3 CD56+). PBMC (106/ml) were
stimulated with live E. coli, L. johnsonii, and
L. sakei cells (106 CFU/ml) and LPS (1 µg/ml).
PHA (10 µg/ml) and culture medium were used as controls. FACS
analysis was performed to determine CD69 expression on lymphocyte
subsets (CD4+, CD8+, and CD19+) and
NK cells (CD3 CD56+) after 5 days of
stimulation. Gentamicin (125 µg/ml) was added to the cultures. Values
are means of duplicate measurements and represent one of three
independent experiments.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 6.
Proliferative response of PBMC. PBMC
(106/ml) were stimulated with live E. coli,
L. johnsonii, and L. sakei cells (106
CFU/ml) and LPS (1 µg/ml). PHA (10 µg/ml) and culture medium were
used as controls. Proliferation was indicated by
[3H]thymidine (1 µg/well) uptake after 3 and 5 days of
stimulation. Gentamicin (125 µg/ml) was added to the cultures. Values
are means ± SD obtained in triplicate. ***, P < 0.001.
|
|
Activation of human NK cells by bacteria requires direct contact
and is dependent on the presence of accessory cells.
The results
for activation antigens and proliferation demonstrated that NK cells
can in fact be partially activated by direct contact to bacteria.
However, the weak proliferative response observed in the purified NK
cell population could reflect the need for accessory cells, such as
macrophages, which were present in the PBMC bulk cultures. Therefore,
to study the dependence of NK cell activation by bacteria on accessory
cells, purified CD3
CD56+ NK cells
(106/ml) were stimulated (i) directly with L. johnsonii or E. coli (106 CFU/ml), (ii)
with macrophages previously primed (12 h) with the same bacterial
strains, and (iii) with a mixture of macrophages and bacteria. Finally,
the percentages of activated NK cells expressing CD25 were determined
after 3 and 5 days of culture (gentamicin at 125 µg/ml) (Fig.
8). Whereas E. coli did not
stimulate NK cells above the levels of control treatments (untreated
cells, NK cells, and macrophages), L. johnsonii alone
induced suboptimal expression of CD25 on NK
cells. This expression was increased in
the presence of macrophages (primed or in combination with live
bacteria). Selective activation of NK cells by L. johnsonii
could be further documented by the production of IFN-
following
stimulation with primed macrophages (936 pg/ml) or macrophages and live
bacteria (1,321 pg/ml). In contrast, E. coli remained unable
to stimulate IFN-
secretion in NK-macrophage cocultures above
control levels (400 pg/ml). It is noteworthy that the induction of the
cytokine response was dependent on the presence of macrophages and
bacteria, as direct stimulation of NK cells with bacteria alone did not result in IFN-
secretion (Fig. 9).
Separation of primed macrophages and bacteria from NK cells by filter
inserts did not result in the induction of CD25 on NK cells,
demonstrating that activation of NK cells is not exclusively based on
monocyte-derived cytokines but requires cell-to-cell contact (data not
shown). These results clearly demonstrate that activation of NK cells
by nonpathogenic bacteria required the help of accessory,
antigen-presenting cells, such as macrophages.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 7.
Proliferative response of purified NK cells
(CD3 CD56+). Purified NK cells
(106/ml) were stimulated with live E. coli and
L. johnsonii cells (106 CFU/ml) and LPS (1 µg/ml). PHA (10 µg/ml) and culture medium were used as controls.
Proliferation was indicated by [3H]thymidine (1 µg/well) uptake after 5 days of stimulation. Gentamicin (125 µg/ml)
was added to the cultures. Values are means ± SD obtained in
triplicate.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 8.
Expression of the cellular activation antigen CD25
(IL-2R chain) on purified NK cells (CD3
CD56+). Purified NK cells (106/ml) were
incubated with (i) nonprimed macrophages (Mo) (5 × 105/ml), (ii) live bacteria (106 CFU/ml;
E. coli or L. johnsonii), (iii) bacterially
primed macrophages, or (iv) a mixture of bacteria and macrophages. FACS
analysis was performed to determine CD25 expression on lymphocyte NK
cells (CD3 CD56+) after 5 days of
stimulation. Gentamicin (125 µg/ml) was added to the cultures. Values
are means of duplicate measurements and represent one of three
independent experiments.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 9.
Secretion of IFN- by purified NK cells
(CD3 CD56+). Purified NK cells
(106/ml) were incubated with (i) nonprimed macrophages (Mo)
(5 × 105/ml), (ii) bacteria (106 CFU/ml;
E. coli or L. johnsonii), (iii) bacterially
primed macrophages, or (iv) a mixture of bacteria and macrophages.
ELISA analysis was performed to determine IFN- secretion by purified
NK cells (CD3 CD56+) after 5 days of
stimulation. Gentamicin (125 µg/ml) was added to the cultures. Values
are means of triplicate measurements and represent one of three
independent experiments.
|
|
 |
DISCUSSION |
The present study on the direct interaction of
nonpathogenic bacteria with human PBMC is based on the assumption that
bacteria and immunocompetent cells may physically interact in definite mucosal environments. The epithelial compartment, the lamina propria, and M-cell pockets are potential sites where commensal, nonpathogenic bacteria may encounter immunocompetent cells. It is well documented that M cells promote the interaction between luminal antigens, including bacteria, and immunocompetent cells (32). The
occurrence of limited bacterial translocation to the lamina propria in
humans has also been reported (6, 38). Although PBMC are
only partially representative of immunocompetent cells in intestinal
mucosal compartments, phenotypical similarities with respect to the
germ line-encoded receptors involved in the recognition of bacterial antigens on lymphocytes and macrophages, such as pattern recognition receptors (27, 39), could constitute the link between both populations and thus may provide important indications of the functional aspects of the mucosal immune response to luminal bacteria. We showed that gram-positive and gram-negative nonpathogenic bacteria induced different cytokine patterns in human PBMC. Whereas all bacteria
induced TNF-
secretion, differences with respect to the induction of
the Th1-like cytokines IL-12 and IFN-
and the inhibitory cytokine
IL-10 were observed. L. johnsonii and L. sakei strongly induced IFN-
and IL-12 but not IL-10. In contrast, the gram-negative E. coli and the gram-negative
bacterium-derived soluble immunomodulator LPS stimulated preferentially
the synthesis of IL-10 and had little or no capacity to induce
IFN-
or IL-12 in human PBMC. These results are in agreement with
reports by Miettinen et al. (28) and Muller-Alouf et al.
(31) comparing different nonpathogenic and pathogenic
gram-positive bacteria with respect to the induction of cytokines in
PBMC. These in vitro data may also reflect the common immunosuppression
observed in patients undergoing endotoxemia (2, 14).
Our interest was then focused on the identification of the cellular
subpopulations activated by different bacterial strains. The analysis
of activation antigens CD69 and CD25 (IL-2R
chain) in stimulated
PBMC bulk cultures indicated that only NK cells upregulating both
markers were activated by bacterial treatment, although the PHA control
suggested that all lymphocyte subsets (CD4+,
CD8+, and CD19+) responded normally to a
mitogenic stimulus. Low expression of CD69 on CD8+ cells
after bacterial treatment could be attributed to a contamination with
CD8dim NK cells rather than a specific activation of CD3+
CD8+ T cells.
Proliferation of PBMC following bacterial stimulation was demonstrated
for all bacteria after 5 days in culture. However, proliferation of
isolated lymphocyte subsets was only observed with CD3
CD56+ NK cells. The fact that the proliferative response
with purified NK cells was 10 times lower than with total PBMC could be
due to (i) a selective stimulation of a particular NK cell subset or
(ii) the dependence on accessory cells for complete activation. A
variety of NK cell receptors, implicated in activation or inhibition of
NK cell effector functions, e.g., proliferation and cytolytic activity,
have been described recently (22, 29, 36). Thus, the
phenotypic characterization of the responsive NK subpopulation will
provide further information on the specificity of the interaction with bacteria.
Coculturing purified NK cells with bacterially primed macrophages
revealed that expression of CD25 is strongly promoted in the presence
of an accessory cell, indicating the requirement for cell contact-based
signals for activation. This could be mediated by the interaction of
costimulatory molecules, such as CD28, CD16, or the CD94 receptor
complex, which were shown to be expressed on human NK cells and which
have key roles in expansion and effector functions (12, 41,
42). The dependence on accessory cell function was also reflected
by the selective induction of IFN-
secretion from NK cells in the
presence of L. johnsonii-primed macrophages or in coculture
with macrophages and L. johnsonii. The synergistic effect on
NK cell activation observed in the combination of macrophages and
bacteria is likely to be based on the additional secretion of
monokines, which engage constitutively expressed monocyte-derived
cytokine receptors on NK cells (9).
Although the secretion of cytokines required the presence of accessory
cells, a direct interaction between bacteria and NK cells, leading to
activation, was demonstrated. This interaction was more intense with
L. johnsonii than with E. coli and could be
linked to different bacterial cell surface determinants, which may
constitute the molecular basis for specific immunomodulatory properties. It is reported that lactobacilli interact with asialo-GM1 receptors on epithelial cells (11, 43). Expression of this receptor on murine NK cells is also reported (33), and it
may also constitute a putative receptor on human NK cells to mediate activation by bacteria (30). Furthermore, the oral
administration of L. johnsonii to healthy volunteers
increased the phagocytic activity of PBMC, suggesting that this
stimulation could take place within the normal homeostasis of the
immune system (37). Thus, activation of
monocytes/macrophages seems a common denominator for both the in vivo
observation following LAB ingestion and the in vitro data showing that
L. johnsonii-primed monocytes mediate NK cell activation and
subsequent IFN-
secretion.
NK cells play an important role in innate immune resistance,
particularly through synthesis of the proinflammatory cytokine IFN-
.
Recently, only a small role for NK cells in the early production of
IFN-
after infection of mice with Listeria monocytogenes
was claimed (33). Our data suggest that NK cells, as well as
macrophages, constitute primary targets for bacterial stimulation. This
is consistent with previous observations that IFN-
production in response to bacteria requires NK cells but not T cells (1). IFN-
production in vitro by activated NK cells is highly dependent on the presence of IL-12, which induces effector maturation and expansion of NK cells and CD8+ T cells. Those cells which
encounter first a foreign antigen play an important role in determining
whether a Th1- or Th2-biased immune response is mounted to an antigenic
challenge. IL-12 is implicated in the mechanisms of an innate immune
response and, at the same time, shifts a developing immune response
towards the "on" set of cell-mediated immunity, which constitutes
one major part of acquired immunity (17). It has been
clearly established that IL-12 and IFN-
mediate protective functions
against intracellular pathogens by inducing monocyte/macrophage
activation (24, 40).
It is essential that NK cell activity remain under stringent and finely
tuned control. The system of inhibitory and stimulatory receptors and
the cytokine microenvironment allow the control of NK cell responses
(10, 19). The role of NK cells in the recognition of
commensal bacterial signals, in part mediated by monocytes, has not
been established. The fact that we demonstrated the induction of a
distinct immune response in human PBMC by nonpathogenic bacteria should
encourage further work to understand the physiology of bacterial
interaction with host cells.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Dept. of
Immunology, Nestlé Research Centre, Vers-Chez-les-Blanc, 1000 Lausanne 26, Switzerland. Phone: 41-21-785-8513. Fax: 41-21-785-8925. E-mail: dirk.haller{at}rdls.nestle.com.
Editor:
J. D. Clements
 |
REFERENCES |
| 1.
|
Bancroft, G. J.,
R. D. Schreiber,
G. C. Bosma,
M. J. Bosma, and E. R. Unanue.
1987.
A T cell-independent mechanism of macrophage activation by interferon-gamma.
J. Immunol.
139:1104-1107[Abstract].
|
| 2.
|
Berg, D. J.,
R. Kuhn,
K. Rajewsky,
W. Muller,
S. Menon,
N. Davidson,
G. Grunig, and D. Rennick.
1995.
Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.
J. Clin. Investig.
96:2339-2347.
|
| 3.
|
Berg, R. D., and D. C. Savage.
1975.
Immune responses of specific pathogen-free and gnotobiotic mice to antigens of indigenous and nonindigenous microorganisms.
Infect. Immun.
11:320-329[Abstract/Free Full Text].
|
| 4.
|
Bohn, E., and I. B. Autenrieth.
1996.
IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
J. Immunol.
156:1458-1468[Abstract].
|
| 5.
|
Cooper, A. M.,
A. D. Roberts,
E. R. Rhoades,
J. E. Callahan,
D. M. Getzy, and I. M. Orme.
1995.
The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.
Immunology
84:423-432[Medline].
|
| 6.
|
Deitch, E. A.,
D. Xu,
L. Qi, and R. D. Berg.
1991.
Bacterial translocation from the gut impairs systemic immunity.
Surgery
109:269-276[Medline].
|
| 7.
|
De Man, J. C.,
M. Rogosa, and M. E. Sharpe.
1960.
A medium for the cultivation of lactobacilli.
J. Appl. Bacteriol.
23:130-135.
|
| 8.
|
Dubos, R.,
R. W. Schaedler,
R. Costello, and P. Hoet.
1965.
Indigenous, normal and autochthonous flora of the gastrointestinal tract.
J. Exp. Med.
122:67-76[Abstract].
|
| 9.
|
Fehniger, T. A.,
M. H. Shah,
M. J. Turner,
J. B. VanDeusen,
S. P. Whitman,
M. A. Cooper,
K. Suzuki,
M. Wechser,
F. Goodsaid, and M. A. Caligiuri.
1999.
Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
J. Immunol.
162:4511-4520[Abstract/Free Full Text].
|
| 10.
|
Fort, M. M.,
M. W. Leach, and D. M. Rennick.
1998.
A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis.
J. Immunol.
161:3256-3261[Abstract/Free Full Text].
|
| 11.
|
Fujiwara, S.,
H. Hashiba,
T. Hirota, and J. F. Forstner.
1997.
Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide.
Appl. Environ. Microbiol.
63:506-512[Abstract].
|
| 12.
|
Galea-Lauri, J.,
D. Darling,
S. U. Gan,
L. Krivochtchapov,
M. Kuiper,
J. Gaken,
B. Souberbielle, and F. Farzaneh.
1999.
Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
J. Immunol.
163:62-70[Abstract/Free Full Text].
|
| 13.
|
Gazzinelli, R. T.,
M. Wysocka,
S. Hayashi,
E. Y. Denkers,
S. Hieny,
P. Caspar,
G. Trinchieri, and A. Sher.
1994.
Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii.
J. Immunol.
153:2533-2543[Abstract].
|
| 14.
|
Gerard, C.,
C. Bruyns,
A. Marchant,
D. Abramowicz,
P. Vandenabeele,
A. Delvaux,
W. Fiers,
M. Goldman, and T. Velu.
1993.
Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.
J. Exp. Med.
177:547-550[Abstract/Free Full Text].
|
| 15.
|
Gibson, P. R.,
H. J. Verhaar,
W. S. Selby, and D. P. Jewell.
1984.
The mononuclear cells of human mesenteric blood, intestinal mucosa and mesenteric lymph nodes: compartmentalization of NK cells.
Clin. Exp. Immunol.
56:445-452[Medline].
|
| 16.
|
Guarner, F., and G. J. Schaafsma.
1998.
Probiotics.
Int. J. Food Microbiol.
39:237-238[CrossRef][Medline].
|
| 17.
|
Hall, S. S.
1995.
IL-12 at the crossroads.
Science
268:1432-1434[Free Full Text].
|
| 18.
|
Hessle, C.,
L. A. Hanson, and A. E. Wold.
1999.
Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production.
Clin. Exp. Immunol.
116:276-282[CrossRef][Medline].
|
| 19.
|
Hogan, P. G.,
A. J. Hapel, and W. F. Doe.
1985.
Lymphokine-activated and natural killer cell activity in human intestinal mucosa.
J. Immunol.
135:1731-1738[Abstract].
|
| 20.
|
Kenworthy, R.
1971.
Observations on the reaction of the intestinal mucosa to bacterial challenge.
J. Clin. Pathol.
24:138-142.
|
| 21.
|
Kiessling, R.,
E. Klein, and H. Wigzell.
1975.
"Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype.
Eur. J. Immunol.
5:112-117[Medline].
|
| 22.
|
Lanier, L. L.
1998.
NK cell receptors.
Annu. Rev. Immunol.
16:359-393[CrossRef][Medline].
|
| 23.
|
Lidbeck, A., and C. E. Nord.
1993.
Lactobacilli and the normal human anaerobic microflora.
Clin. Infect. Dis.
16(Suppl. 4):S181-S187.
|
| 24.
|
MacMicking, J.,
Q. W. Xie, and C. Nathan.
1997.
Nitric oxide and macrophage function.
Annu. Rev. Immunol.
15:323-350[CrossRef][Medline].
|
| 25.
|
Marteau, P.,
J. P. Verman,
J. P. Dehennin,
S. Bord,
D. Brassart,
P. Pochart,
J. F. Desjeux, and J. C. Rambaud.
1997.
Effects of intrajejunal perfusion and chronic ingestion of Lactobacillus johnsonii strain La 1 on serum concentration and jejunal secretions of immunoglobulins and serum proteins in healthy humans.
Gastroenterol. Clin. Biol.
21:293-298[Medline].
|
| 26.
|
Mastroeni, P.,
J. A. Harrison,
J. A. Chabalgoity, and C. E. Hormaeche.
1996.
Effect of interleukin-12 neutralization on host resistance and gamma interferon production in mouse typhoid.
Infect. Immun.
64:189-196[Abstract].
|
| 27.
|
Medzhitov, R.,
P. Preston-Hurlburt, and C. A. J. Janeway.
1997.
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.
Nature
388:394-397[CrossRef][Medline].
|
| 28.
|
Miettinen, M.,
S. Matikainen,
J. Vuopio-Varkila,
J. Pirhonen,
K. Varkila,
M. Kurimoto, and I. Julkunen.
1998.
Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells.
Infect. Immun.
66:6058-6062[Abstract/Free Full Text].
|
| 29.
|
Moretta, A.,
C. Bottino,
M. Vitale,
D. Pende,
R. Biassoni,
M. C. Mingari, and L. Moretta.
1996.
Receptors for HLA class-I molecules in human natural killer cells.
Annu. Rev. Immunol.
14:619-648[CrossRef][Medline].
|
| 30.
|
Muller, C.,
M. Szangolies,
S. Kukel,
M. Kiehl,
M. Sorice,
T. Griggi,
L. Lenti, and R. Bauer.
1996.
Characterization of autoantibodies to natural killer cells in HIV-infected patients.
Scand. J. Immunol.
43:583-592[CrossRef][Medline].
|
| 31.
|
Muller-Alouf, H.,
J. E. Alouf,
D. Gerlach,
J. H. Ozegowski,
C. Fitting, and J. M. Cavaillon.
1994.
Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat killed streptococci and lipopolysaccharide.
Infect. Immun.
62:4915-4921[Abstract/Free Full Text].
|
| 32.
|
Neutra, M. R.
1999.
M cells in antigen sampling in mucosal tissues.
Curr. Top. Microbiol. Immunol.
236:17-32[Medline].
|
| 33.
|
Ohteki, T.,
T. Fukao,
K. Suzue,
C. Maki,
M. Ito,
M. Nakamura, and S. Koyasu.
1999.
Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells.
J. Exp. Med.
189:1981-1986[Abstract/Free Full Text].
|
| 34.
|
Pang, G.,
A. Buret,
R. T. Batey,
Q. Y. Chen,
L. Couch,
A. Cripps, and R. Clancy.
1993.
Morphological, phenotypic and functional characteristics of a pure population of CD56+ CD16 CD3 large granular lymphocytes generated from human duodenal mucosa.
Immunology
79:498-505[Medline].
|
| 35.
|
Perdigon, G.,
S. Alvarez,
M. Rachid,
G. Aguero, and N. Gobbato.
1995.
Immune system stimulation by probiotics.
J. Dairy Sci.
78:1597-1606[Abstract].
|
| 36.
|
Ross, G. D., and V. Vetvicka.
1993.
CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions.
Clin. Exp. Immunol.
92:181-184[Medline].
|
| 37.
|
Schiffrin, E. J.,
F. Rochat,
H. Link-Amster,
J. M. Aeschlimann, and A. Donnet-Hughes.
1995.
Immunomodulation of human blood cells following the ingestion of lactic acid bacteria.
J. Dairy Sci.
78:491-497[Abstract].
|
| 38.
|
Sedman, P. C.,
J. Macfie,
P. Sagar,
C. J. Mitchell,
J. May,
B. Mancey-Jones, and D. Johnstone.
1994.
The prevalence of gut translocation in humans.
Gastroenterology
107:643-649[Medline].
|
| 39.
|
Stahl, P. D., and R. A. Ezekowitz.
1998.
The mannose receptor is a pattern recognition receptor involved in host defense.
Curr. Opin. Immunol.
10:50-55[CrossRef][Medline].
|
| 40.
|
Trinchieri, G.
1995.
Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.
Annu. Rev. Immunol.
13:251-276[Medline].
|
| 41.
|
Voss, S. D.,
J. Daley,
J. Ritz, and M. J. Robertson.
1998.
Participation of the CD94 receptor complex in costimulation of human natural killer cells.
J. Immunol.
160:1618-1626[Abstract/Free Full Text].
|
| 42.
|
Warren, H. S., and B. F. Kinnear.
1999.
Quantitative analysis of the effect of CD16 ligation on human NK cell proliferation.
J. Immunol.
162:735-742[Abstract/Free Full Text].
|
| 43.
|
Yamamoto, K.,
T. Miwa,
H. Taniguchi,
T. Nagano,
K. Shimamura,
T. Tanaka, and H. Kumagai.
1996.
Binding specificity of Lactobacillus to glycolipids.
Biochem. Biophys. Res. Commun.
228:148-152[CrossRef][Medline].
|
Infection and Immunity, February 2000, p. 752-759, Vol. 68, No. 2
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Fink, L. N., Zeuthen, L. H., Christensen, H. R., Morandi, B., Frokiaer, H., Ferlazzo, G.
(2007). Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses. Int Immunol
19: 1319-1327
[Abstract]
[Full Text]
-
Shida, K., Suzuki, T., Kiyoshima-Shibata, J., Shimada, S.-i., Nanno, M.
(2006). Essential Roles of Monocytes in Stimulating Human Peripheral Blood Mononuclear Cells with Lactobacillus casei To Produce Cytokines and Augment Natural Killer Cell Activity.. CVI
13: 997-1003
[Abstract]
[Full Text]
-
Benyacoub, J., Perez, P. F., Rochat, F., Saudan, K. Y., Reuteler, G., Antille, N., Humen, M., De Antoni, G. L., Cavadini, C., Blum, S., Schiffrin, E. J.
(2005). Enterococcus faecium SF68 Enhances the Immune Response to Giardia intestinalis in Mice. J. Nutr.
135: 1171-1176
[Abstract]
[Full Text]
-
Humen, M. A., De Antoni, G. L., Benyacoub, J., Costas, M. E., Cardozo, M. I., Kozubsky, L., Saudan, K.-Y., Boenzli-Bruand, A., Blum, S., Schiffrin, E. J., Perez, P. F.
(2005). Lactobacillus johnsonii La1 Antagonizes Giardia intestinalis In Vivo. Infect. Immun.
73: 1265-1269
[Abstract]
[Full Text]
-
Boekhorst, J., Siezen, R. J., Zwahlen, M.-C., Vilanova, D., Pridmore, R. D., Mercenier, A., Kleerebezem, M., de Vos, W. M., Brussow, H., Desiere, F.
(2004). The complete genomes of Lactobacillus plantarum and Lactobacillus johnsonii reveal extensive differences in chromosome organization and gene content. Microbiology
150: 3601-3611
[Abstract]
[Full Text]
-
Tannock, G. W.
(2004). A Special Fondness for Lactobacilli. Appl. Environ. Microbiol.
70: 3189-3194
[Full Text]
-
Pridmore, R. D., Berger, B., Desiere, F., Vilanova, D., Barretto, C., Pittet, A.-C., Zwahlen, M.-C., Rouvet, M., Altermann, E., Barrangou, R., Mollet, B., Mercenier, A., Klaenhammer, T., Arigoni, F., Schell, M. A.
(2004). The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533. Proc. Natl. Acad. Sci. USA
101: 2512-2517
[Abstract]
[Full Text]
-
Benyacoub, J., Czarnecki-Maulden, G. L., Cavadini, C., Sauthier, T., Anderson, R. E., Schiffrin, E. J., von der Weid, T.
(2003). Supplementation of Food with Enterococcus faecium (SF68) Stimulates Immune Functions in Young Dogs. J. Nutr.
133: 1158-1162
[Abstract]
[Full Text]
-
Ibnou-Zekri, N., Blum, S., Schiffrin, E. J., von der Weid, T.
(2003). Divergent Patterns of Colonization and Immune Response Elicited from Two Intestinal Lactobacillus Strains That Display Similar Properties In Vitro. Infect. Immun.
71: 428-436
[Abstract]
[Full Text]
-
Karlsson, H., Hessle, C., Rudin, A.
(2002). Innate Immune Responses of Human Neonatal Cells to Bacteria from the Normal Gastrointestinal Flora. Infect. Immun.
70: 6688-6696
[Abstract]
[Full Text]
-
Haller, D., Serrant, P., Granato, D., Schiffrin, E. J., Blum, S.
(2002). Activation of Human NK Cells by Staphylococci and Lactobacilli Requires Cell Contact-Dependent Costimulation by Autologous Monocytes. CVI
9: 649-657
[Abstract]
[Full Text]
-
Robinson, K., Neal, K. R., Howard, C., Stockton, J., Atkinson, K., Scarth, E., Moran, J., Robins, A., Todd, I., Kaczmarski, E., Gray, S., Muscat, I., Slack, R., Ala'Aldeen, D. A. A.
(2002). Characterization of Humoral and Cellular Immune Responses Elicited by Meningococcal Carriage. Infect. Immun.
70: 1301-1309
[Abstract]
[Full Text]
-
Tsirpouchtsidis, A., Hurwitz, R., Brinkmann, V., Meyer, T. F., Haas, G.
(2002). Neisserial Immunoglobulin A1 Protease Induces Specific T-Cell Responses in Humans. Infect. Immun.
70: 335-344
[Abstract]
[Full Text]
-
von der Weid, T., Bulliard, C., Schiffrin, E. J.
(2001). Induction by a Lactic Acid Bacterium of a Population of CD4+ T Cells with Low Proliferative Capacity That Produce Transforming Growth Factor {beta} and Interleukin-10. CVI
8: 695-701
[Abstract]
[Full Text]
-
Neeser, J.-R., Granato, D., Rouvet, M., Servin, A., Teneberg, S., Karlsson, K.-A.
(2000). Lactobacillus johnsonii La1 shares carbohydrate-binding specificities with several enteropathogenic bacteria. Glycobiology
10: 1193-1199
[Abstract]
[Full Text]